Fri. 24 May 2024, 2:37am ET
Benzinga
News
- The advisory committee offers valuable non-binding recommendations for the FDA
- Blood test offers a convenient non-invasive screening option that overcomes barriers associated with current non-invasive screening tests
- Shield remains on track to become the first FDA-approved blood test that meets performance requirements for Medicare coverage1